Thursday, 28 March 2024


Quantum Surgical raises Series A capital from Ally Bridge

06 June 2018 | News

Quantum Surgical is developing next-generation robotic solutions for minimally invasive cancer therapies.

Image credit- kenresearch.com

Image credit- kenresearch.com

Ally Bridge Group (ABG), a China-centered healthcare investor, has completed a Series A investment, as the first part of a total of $50 million raise, in Quantum Surgical, an innovative surgical robotics company in France.

Quantum Surgical is developing next-generation robotic solutions for minimally invasive cancer therapies. Quantum's predecessor company Medtech SA, a leading French neurosurgical robotics company, was acquired by global orthopaedics giant Zimmer Biomet in 2016 after an investment from ABG in 2015.

Lifetech Scientific, a leading innovative medtech company in China, has also participated in the investment through its joint venture with ABG and will collaborate with Quantum Surgical in China market.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account